Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T S Lawrence

Showing results (21-30 of 135) with videos related to

Pageof 14
Sort By:
Endocrinology|April 1, 1980
Binding of human chorionic gonadotropin by rat cumuli oophori and granulosa cells: a comparative studyT S Lawrence, N Dekel, W H Beers
Seminars in Oncology|April 1, 1997
Gemcitabine-mediated radiosensitizationT S Lawrence, A Eisbruch, D S Shewach
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effectsT S Lawrence, M A Davis, J Maybaum
Cancer Chemotherapy and Pharmacology|May 10, 2000
The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitizationM Chen, A M Hough, T S Lawrence
Radiation Research|August 10, 2000
Lack of effect of TP53 status on fluorodeoxyuridine-mediated radiosensitizationT S Lawrence, R Burke, M A Davis
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitizationJ D Naida, M A Davis, T S Lawrence
Journal of the National Cancer Institute|September 4, 1996
Radiosensitizing nucleosidesC J McGinn, D S Shewach, T S Lawrence
Frontiers of Radiation Therapy and Oncology|January 1, 1996
3-D conformal radiation therapy in upper gastrointestinal cancer. The University of Michigan experienceT S Lawrence, M L Kessler, J M Robertson
Oncology (Williston Park, N.Y.)|October 1, 1993
Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancerT S Lawrence, M L Kessler, J M Robertson
Oncology (Williston Park, N.Y.)|August 1, 1995
Current status of radiation sensitization by fluoropyrimidinesA T Pu, J M Robertson, T S Lawrence
Pageof 14

Showing results (21-30 of 135) with videos related to

Sort By:
Pageof 14
Endocrinology|April 1, 1980
Binding of human chorionic gonadotropin by rat cumuli oophori and granulosa cells: a comparative studyT S Lawrence, N Dekel, W H Beers
Seminars in Oncology|April 1, 1997
Gemcitabine-mediated radiosensitizationT S Lawrence, A Eisbruch, D S Shewach
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effectsT S Lawrence, M A Davis, J Maybaum
Cancer Chemotherapy and Pharmacology|May 10, 2000
The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitizationM Chen, A M Hough, T S Lawrence
Radiation Research|August 10, 2000
Lack of effect of TP53 status on fluorodeoxyuridine-mediated radiosensitizationT S Lawrence, R Burke, M A Davis
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitizationJ D Naida, M A Davis, T S Lawrence
Journal of the National Cancer Institute|September 4, 1996
Radiosensitizing nucleosidesC J McGinn, D S Shewach, T S Lawrence
Frontiers of Radiation Therapy and Oncology|January 1, 1996
3-D conformal radiation therapy in upper gastrointestinal cancer. The University of Michigan experienceT S Lawrence, M L Kessler, J M Robertson
Oncology (Williston Park, N.Y.)|October 1, 1993
Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancerT S Lawrence, M L Kessler, J M Robertson
Oncology (Williston Park, N.Y.)|August 1, 1995
Current status of radiation sensitization by fluoropyrimidinesA T Pu, J M Robertson, T S Lawrence
Pageof 14